Print
Peplin Limited
(
PEP.AX
) In A Strong Position Despite Loss
8/8/2006 6:29:23 PM
Skin cancer therapeutics firm Peplin Ltd says it is in a strong position, with two anti-cancer drugs in the latter stages of development and $31 million in cash.